Indonesia Energy Corporation Limited vs Zoetis Inc — how do they compare? Indonesia Energy Corporation Limited trades at $2.79 (market cap $43.24M), while Zoetis Inc trades at $74.33 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 698.4× Indonesia Energy Corporation Limited's market cap, and Zoetis Inc pays a 2.9% dividend while Indonesia Energy Corporation Limited pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indonesia Energy Corporation Limited for 24 Days and Zoetis Inc for 70 Days on average.
| INDO | ZTS | |
|---|---|---|
Market Cap | $43.24M | $30.20B |
Volume | 116,953 | 6,175,327 |
Sector | Energy | Health |
52-Week High | $6.74 | $147.53 |
52-Week Low | $2.49 | $69.09 |
Typical Hold Time | 24 Days | 70 Days |
Enterprise Value | $38.18M | $37.76B |
Dividend Yield | — | 2.9% |
Signals from Pluang's Aura AI — not financial advice
INDO trades at $2.79, up 0.72% on the day, amid a bearish technical signal. The company reported a net loss of $5.10M on $2.01M revenue for 2025, with negative profit margins. Recent news highlights operational progress, including oil discovery at the K-29 well and participation in investment conferences.
Despite unanimous analyst buy ratings, INDO faces significant financial challenges with persistent losses and negative cash flow from operations. The stock's outlook hinges on successful production scaling from new wells, but execution risks and weak fundamentals present substantial downside potential for investors.
Zoetis (ZTS) trades at $71.55, showing modest daily gains of 0.32% amid a challenging market environment. The stock faces bearish technical signals with mixed earnings performance, having beaten estimates in Q2 2026 but missing in Q1. Despite recent headwinds in U.S. companion animal sales, the company maintains strong profitability with 71.67% gross margins and 27.69% net income margins. Analyst consensus remains positive with a $87.33 price target, though technical indicators suggest near-term pressure with support at $70-$71.
Zoetis presents a compelling value opportunity with attractive valuation multiples (P/E 11.92, EV/EBITDA 9.4) and robust fundamentals, though near-term risks include competitive pressures in pet medications and weakening U.S. veterinary clinic traffic. The company's international and livestock segments show resilience, supporting long-term growth potential despite current market skepticism.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.
Read more on INDO →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →